1-5 of 5
Y Akanuma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

N Kubota, K Tobe, Y Terauchi, K Eto, T Yamauchi, R Suzuki, Y Tsubamoto, K Komeda, R Nakano, H Miki, S Satoh, H Sekihara, S Sciacchitano, M Lesniak, S Aizawa, R Nagai, S Kimura, Y Akanuma, S I Taylor, T Kadowaki
Journal: Diabetes
Diabetes 2000;49(11):1880–1889
https://doi.org/10.2337/diabetes.49.11.1880
Published: 01 November 2000
View articletitled, Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.
Open the PDF for Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. in another window
Meeting Abstracts

Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes.

Y Terauchi, N Kubota, H Tamemoto, H Sakura, R Nagai, Y Akanuma, S Kimura, T Kadowaki
Journal: Diabetes
Diabetes 2000;49(1):82–86
https://doi.org/10.2337/diabetes.49.1.82
Published: 01 January 2000
View articletitled, Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes.
Open the PDF for Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes. in another window
Meeting Abstracts

A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.

K Murakami, K Tobe, T Ide, T Mochizuki, M Ohashi, Y Akanuma, Y Yazaki, T Kadowaki
Journal: Diabetes
Diabetes 1998;47(12):1841–1847
https://doi.org/10.2337/diabetes.47.12.1841
Published: 01 December 1998
View articletitled, A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Open the PDF for A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats. in another window
Journal Articles

Initial Phase II Clinical Studies on Midaglizole (DG-5128): A New Hypoglycemic Agent

S Kawazu, M Suzuki, K Negishi, J Ishii, H Sando, H Katagiri, Y Kanazawa, S Yamanouchi, Y Akanuma, H Kajinuma, K Suzuki, K Watanabe, T Itoh, T Kobayashi, K Kosaka
Journal: Diabetes
Diabetes 1987;36(2):221–226
https://doi.org/10.2337/diab.36.2.221
Published: 01 February 1987
View articletitled, Initial Phase II Clinical Studies on Midaglizole (DG-5128): A New Hypoglycemic Agent
Open the PDF for Initial Phase II Clinical Studies on Midaglizole (DG-5128): A New Hypoglycemic Agent in another window
Journal Articles

Effects of Anti-insulin Receptor Autoantibodies on the Metabolism of Human Adipocytes

M Kasuga, MD, Y Akanuma, MD, T Tsushima, MD, Y Iwamoto, MD, K Kosaka, MD, M Kibata, MD, K Kawanishi, MD
Journal: Diabetes
Diabetes 1978;27(9):938–945
https://doi.org/10.2337/diab.27.9.938
Published: 01 September 1978
View articletitled, Effects of Anti-insulin Receptor Autoantibodies on the Metabolism of Human Adipocytes
Open the PDF for Effects of Anti-insulin Receptor Autoantibodies on the Metabolism of Human Adipocytes in another window